Advertisement

European Journal of Dermatology

, Volume 25, Issue 5, pp 488–490 | Cite as

Remission of an epidermodysplasia verruciformis-like eruption in an HIV-positive man long after immune restoration

  • Anne Lise Lecapitaine
  • Véronique Perronne
  • Françoise Granier
Correspondence
  • 21 Downloads

Keywords

Isotretinoin Imiquimod Aseptic Meningitis Cidofovir Etretinate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific HPV. J Invest Dermatol 1984; 83: 18.-25s.CrossRefGoogle Scholar
  2. 2.
    Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32: 579–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Rallis E, Paparizos V, Kyriakis K, Katsambas A. Treatment of epidermodysplasia verruciformis in human immunodeficiency virus-positive patients. J Eur Acad Dermatol Venereol 2009; 231:95–6.Google Scholar
  4. 4.
    Kroft EB, Melchers WJ, Blokx WA, de Hoop D, Warris A. A generalized skin eruption in a human immunodeficiency virus-infected boy. J Eur Acad Dermatol Venereol 2008; 2: 896–7.CrossRefGoogle Scholar
  5. 5.
    Carré D, Dompmartin A, Verdon R, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol 2003; 42: 296–300.PubMedCrossRefGoogle Scholar
  6. 6.
    Mermet I, Guerrini JS, Cairey-Remonnay S, et al. Cervical intraepithelial neoplasia associated with epidermodysplasia verruciformis HPV in an HIV-infected patient: a manifestation of immune restoration syndrome. Eur J Dermatol 2007; 17: 149–52.PubMedGoogle Scholar
  7. 7.
    Haas N, Fuchs PG, Hermes B, Henz BM. Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol 2001; 145: 669–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Lee KC, Risser J, Bercovitch L. What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients? Arch Dermatol 2010; 146: 903–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Jacobelli S, Laude H, Carlotti A, et al. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Arch Dermatol 2011; 147: 590–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Darwich E, Darwich L, Ca˜nadas MP, et al. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir. J Am Acad Dermatol 2011; 65: e43–5.PubMedCrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2015

Authors and Affiliations

  • Anne Lise Lecapitaine
    • 1
  • Véronique Perronne
    • 1
  • Françoise Granier
    • 1
  1. 1.Department of Internal medicine and Infectious DiseasesFrançois Quesnay General HospitalMantes-la-JolieFrance

Personalised recommendations